A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
Clinical trial NCT06150820 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06150820
- Sponsor
- Astellas Gene Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2027-06-30
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.